Global GDP will drop three percent below pre-pandemic estimates by the end of 2021. Many Western nations see “deeper and longer-lasting” effects compared to China and other Asian economies, a study suggests...
Blog
Risk factor for COVID-related hospitalization for renal disease patients
An analysis of Geisinger’s electronic health records has revealed chronic kidney disease to be the leading risk factor for hospitalization from COVID-19. A team of Geisinger researchers studied the health records...
COVID-19 can impact young children’s hearts
A 2-month-old infant diagnosed with COVID-19 experienced reversible myocardial injury and heart failure, similar to COVID-19 related heart issues seen in adults, according to a case published in JACC: Case Reports. The...
COVID-19: How US Universities Responded
As the COVID-19 pandemic began in the United States, universities were forced to make difficult operational decisions to help slow the spread of the disease and protect their students, faculty, staff, and community...
Herpes virus decoded
Until now, scientists had assumed that there are about 80 so-called open reading frames (ORFs) in the genome of herpes simplex virus 1 (HSV-1). These are the locations in the genome where the information in the DNA is...
How the immune system reacts to hepatitis C viruses
If a virus penetrates a cell, the immune system reacts immediately and produces the signalling protein interferon. This protein activates hundreds of highly specialised defence mechanisms in all surrounding cells, which...
COVID-19 triggers OCD in children and young people
Many children and young people with obsessive thoughts and compulsions experience that their OCD, anxiety and depressive symptoms worsen during a crisis such as COVID-19. This is shown by a new research result from...
Nanobodies that neutralize SARS-CoV-2
Two separate studies have identified nanobodies – which could be produced less expensively than monoclonal antibodies – that bind tightly to the SARS-CoV-2 spike protein and efficiently neutralize SARS-CoV-2...
COVID-19: Enzyme targeted by the virus also influences gut inflammation
An enzyme that helps COVID-19 infect the body also plays a role in inflammation and patient outcomes in inflammatory bowel disease (IBD), according to a new study led by Cedars-Sinai. The findings raise the possibility...
Loss of taste and smell with headaches could be an early marker of COVID-19
Delirium, accompanied by a fever, could be an early symptom of COVID-19. This is the main conclusion drawn by a scientific research review carried out by researchers from the Universitat Oberta de Catalunya (UOC) and...


